Daniel Alejandro Mazal

Ingeniería en electrónica (Buenos Aires 1984), Física de la radioterapia (CNEA, 1984) ; Master en Física Radiológica (Tolouse y Paris, 1986), Doctorado en Física Radiológica (Toulouse y Paris, 1990, Radioterapia esterotáxica).: 36.93 Publications: 140

Universidad de Buenos Aires (1980-1984), Academia Nacional de Medicina de Argentina (1982-1984), Instituto Curie de Paris (1985-2018). Últimas posiciones: director técnico del Centro de Protonterapia y Jefe de Servicio de Física Médica.

Massachusetts Gen Hospital & Harvard Medical School, Boston, USA (2003-2004), Indiana University Cyclotron Facility, Bloomington, Usa (1998).

CERN International Strategy Committee for Medical Applications. (2014) ; Conseil Scientifique National de Hadrontherapie, France (2000) ; The Belgian Hadrontherapy Centre Foundation (2012) ; Scientific or expert advisor for Industry : IBA, IBA dosimetry, Varian Particles, Siemens. Tomotherapy . Consejero cientifico en Wanjie (China) , Cape Town (South Africa) Indiana y New York (USA), Trento (Italy), Seoul (Korea), Caen (France), Maastro (Netherlands), Buenos Aires (Argentina), MedAustron (Austria) ; Scientific Council Argentinian Embassy in France.

Physics in Medecine and Biology, Medical Physics, Physica Medica, Radiotherapy and Oncology, Radiation Protection Dosimetry, Radioprotection, Cureus, …

PTCOG : Particle Therapy Cooperative group (Chairman 2010-2013) ; ESTRO (European Society for Radiotherapy and Oncology) ; SFPM (Societé Francaise de Physique Médicale ; PMSF (Physiciens Médicaux Sans Frontière).

Master Medical Physics, Faculté de Medecine, Paris Sud University; Particle Therapy School ESTRO (Europ Soc Radiother & Oncol) ; Educational Workshop PTCOG (Particle Therapy Cooperative Group); Inter-University diploma High technicity radiation therapy and University Diploma Radiation Biology and radiation protection in radiation therapy, France ; AAPM summer school , Colorado Spring, Co, USA,2015. Supervision permanente de master, doctorados, recepcion de estudiantes y charlas invitadas en todo el mundo alrededor de 10/año.

por más de 50M€ : (1) MIGAC: New protontherapy center of Institut Curie ; (2) Grant Canceropole (a) Targeted protontherapy for pediatric and adult tumors: Technical optimization, radiobiology and socio-economic evaluation. (b) towards dynamic protontherapy ; (3) Grant Physicancer : DEDIPRO - Development of a new diamond detector and a fast Monte Carlo TPS for pulsed high dose rate proton beam therapy : (4) Industrials and regional grants: Areva 1-2-3, Feder, Varian,… (5) European Commission INFRAIA-02-2017
 INSPIRE : INfraStructure in Proton International Research (6) IDEX Paris-Saclay, NanoTheRad nanoparticulas en medicina.

RG Score